A Retrospective Observational Study in the Expanded Access Program of Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer (BEACON EAP Follow-up Study )
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Primary outcome(s): Overall survival
创建时间：
2022-07-15
